Man dies in Tsing Yi traffic accident; police seek witnesses for investigation.

2026-08-14 01:39 Last Updated At：01:48

Fatal traffic accident in Tsing Yi

Police are investigating a fatal traffic accident happened in Tsing Yi yesterday (August 13), in which a man died.

Police received a report at 7.39pm that a man was found lying unconscious on a medium goods vehicle (MGV) on Tsing Yi Road.

Police officers sped to the scene. Sustaining no superficial injury, the 44-year-old man was rushed to Yan Chai Hospital in unconscious state and was certified dead at 8.45pm.

Initial investigation revealed that the man reportedly collapsed while driving the MGV travelling along Tsing Yi Road towards Tsuen Wan earlier. The MGV suspectedly lost control and rammed into a kerb.

Investigation by the Special Investigation Team of Traffic, New Territories South is underway.

Anyone who witnessed the accident or has any information to offer is urged to contact the investigating officers on 3661 1344.

Hong Kong Health Secretary Visits Hainan to Strengthen Medical Collaboration and Innovation

Secretary for Health leads delegation to commence visit to Hainan Province

The Secretary for Health, Professor Lo Chung-mau, today (August 13) led a delegation to commence their visit to Hainan Province to meet with local health officials and visit the Boao Lecheng International Medical Tourism Pilot Zone (Pilot Zone) in Hainan.

Professor Lo met with Deputy Director of the Hainan Medical Products Administration Mr Wang Gang in the morning, and highlighted the important measures put forward by the Hong Kong Special Administrative Region (HKSAR) Government in the aspect of developing Hong Kong into an international health and medical innovation hub.

Professor Lo said, "Hong Kong is proactively aligning with the direction of the National 15th Five-Year Plan and pressing ahead with the development of Hong Kong into an international health and medical innovation hub by complementing technological innovation with institutional innovation. We are enhancing the regulatory standards for drugs and medical devices in Hong Kong on all fronts, including the implementation of the '1+' drug approval mechanism, the establishment of the Hong Kong Centre for Medical Products Regulation within this year, and the implementation of the 'primary evaluation' mechanism for new drug registration since March this year. In addition, Hong Kong is actively taking forward the standardisation of clinical data in the Guangdong-Hong Kong-Macao Greater Bay Area, with a view to expediting the registration and launch of innovative drugs and medical devices in Hong Kong, the Mainland and overseas markets."

At his subsequent meeting with the Director of the Health Commission of Hainan Province, Mr Li Wenxiu, the two sides had a detailed exchange on issues including the development of Chinese medicine (CM), the high-quality development of public hospitals, and information sharing on the prevention and control of diseases.

Professor Lo said, "The HKSAR Government has long been actively promoting the development of CM, including the release of the first Chinese Medicine Development Blueprint last year, and the commissioning of the two flagship projects for CM development, namely The Chinese Medicine Hospital of Hong Kong and the permanent premises of the Government Chinese Medicines Testing Institute. These measures will further consolidate Hong Kong's role as a bridgehead for the global expansion of CM, to better serve and contribute to the overall national development of CM."

Regarding the high-quality development of public hospitals, Professor Lo emphasised that the HKSAR Government will continue to actively promote the accreditation of more public hospitals under the China's International Hospital Accreditation Standards (2021 Version), with a view to ensuring the management and healthcare quality of local hospitals are on par with international standards while demonstrating the excellence of the national healthcare standards to the international community, thereby facilitating the national standards to go global.

In the afternoon, the delegation visited the Boao Hope City Ever Lasting International Innovation Medicine Exhibition, Ruijin Hainan Hospital (Boao Research Hospital), affiliated with Shanghai Jiao Tong University School of Medicine,and the Boao Yiling Life Care Centerlocated in the Pilot Zone, and met with the Chief Director of the Administration of the Pilot Zone, Mr Fu Sheng. Professor Lo said, "Serving as an important strategic node of the country's healthcare reform, the Pilot Zone is the only special medical zone on the Mainland benefitting from preferential policies. Focusing on introducing innovative drugs and medical devices from around the world and developing medical tourism, the Pilot Zone is a pioneer of the country's efforts to promote real-world data studies and a testing ground for major national projects of innovation in new drugs and healthcare technologies. Hainan Province's accumulated experience in areas such as the approval of drugs and medical devices for clinical use and the development of cross-boundary healthcare serves as a valuable reference for Hong Kong.

"Hong Kong and Hainan Province enjoy a close co-operative relationship. On the basis of complementarity and mutual benefits, we will further promote exchanges and mutual learning of experiences between the two places in the healthcare field, and jointly promote the development of 'Healthy China'."

Members of the delegation include the Director of Health, Dr Ronald Lam; the Senior Advisor (Secretary for Health's Office), Dr Joe Fan; the Director of the Real-World Study and Application Centre, Professor Cheung Ching-lung; as well as officers of the Health Bureau, the Department of Health and the Hospital Authority. They will visit a local pharmaceutical enterprise tomorrow before returning to Hong Kong in the afternoon.